Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies


  • Maha I.A. Moaty National Research Centre, Nutrition and Food Sciences Department, Cairo
  • Suzanne Fouad National Research Centre, Nutrition and Food Sciences Department, Cairo
  • Salwa M. El Shebini National Research Centre, Nutrition and Food Sciences Department, Cairo
  • Yusr I. Kazem National Research Centre, Nutrition and Food Sciences Department, Cairo
  • Salwa T. Tapozada National Research Centre, Nutrition and Food Sciences Department, Cairo



Vitamin D, Parathyroid hormones, Bone specific alkaline phosphatase, Doum, Metabolic syndrome


AIM: To investigate the relation between bone parameters and the metabolic syndrome criteria, before and after the administration of two different natural dietary supplements in middle aged working obese Egyptian women suffering from metabolic syndrome (MetS).

SUBJECTS AND METHODS: Fifty eight middle aged obese female volunteers suffering from metabolic syndrome were divided into two groups. During the first period, group (A) consumed a low caloric diet and nutritional supplement consisting of doum flour biscuits, while group (B) consumed whole meal wheat flour biscuit with the same instructions. During the second period, both supplements were omitted. Assessment of blood pressure, relevant anthropometric parameters, lipid accumulation product, fasting blood glucose, uric acid, 25 hydroxy vitamin D (25 (OH) D), parathyroid hormone (PTH) and bone-specific alkaline phosphatase were performed.

RESULTS: Data showed that although both supplements improved the MetS criteria and the bone health parameters, the supplement containing the doum flour proved to be more effective.

CONCLUSION: These results confirm the benefit of doum in improving bone health parameter [25 (OH) D/PTH axis] in the MetS patients, beside the MetS criteria. So, we can conclude that natural effective supplements lead towards the optimization of biochemical parameters in favor of a healthy outcome.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Mottillo S, Filion KB, Genest J, The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56:1113-1132.


Alberti K; Zimmet T. "Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications". World Health Organization, 2013: pp. 32–33.

Lips P. Worldwide status of vitamin D nutrition, J Steroid Biochem Mol Biol. 2010;121(1–2):297–300.


Wielders JP, Wijnberg FA. Preanalytical stability of 25 (OH) vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem. 2009;55(8):1584-1585.


Soares MJ, Murhadi LL, Kurpad AV, et al. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev. 2012;13(7):592–605.


Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. Journal of Clinical Endocrinology and Metabolism. 2011;96(5):1320–1326.

PMid:21325456 PMCid:PMC3203623

Ku YC, Liu ME, Ku CS et al. Relationship between vitamin D deficiency and cardiovascular disease. World Journal of Cardiology. 2013;5(9):337–346.

PMid:24109497 PMCid:PMC3783986

Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33:1379–1381.

PMid:20215450 PMCid:PMC2875459

Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Annals of Internal Medicine. 2010;152 (5):307–314.

PMid:20194237 PMCid:PMC3211092

Karhapää P, Pihlajamäki J, Pörsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010;268:604–610.


Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PloS Medicine. 2013;10 (2).

PMid:23393431 PMCid:PMC3564800

Kress BC. Bone alkaline phosphatase: methods of quantitation and clinical utility. J Clin Ligand Assay. 1998;21(2):139-148.

Kress BC, Mizrahi IA, Armour KW, et al.Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem. 1999;45(7):1009-1017.


AOAC. Official Methods of Analysis. Association of Official Analytical Chemist. EUA, 2000.

Gupta A, Gupta V. Metabolic syndrome: what are the risks for humans? Biosci Trends. 2010;4(5): 204-412.


Tanner JM, Hiernau J, Jerman S. Growth and physical studies In Human Biology: A guide to field methods. Eds Weiner JS,Lourie SA. IBP. London, Blackwell Scientific Publication. Oxford: UK, 1969.

Taverna MJ, Martínez-Larrad MT, Frechtel GD, et al. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164:559-567.


Barham D, Trinder P. An improved color reagent for determination of blood glucose by oxidase system. Analyst. 1972;97:142-45.


Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chemo. 2011; 20:470- 475.

Wornick DF, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res.1978;19:65-76.

Wielders JP, Wijnberg FA. Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem. 2009;55 (8):1584-1585.


Bouillon R, Coopmans W, De Groote D et al. Immunoradiometric assay of Parathyrin with polyclonal and monoclonal region specific antibodies. Clin Chem. 1990;36(2):271-276.


Garnero P, Delmas PD. Clinical usefulness of markers of bone remodeling in osteoporosis. In: Meunier PJ (ed.). Osteoporosis: Diagnosis and management. London: Martin Dunitz, 1998:79-101.

Fossati P, Prencipe L, Berti G. Use of 3, 5-Dichloro-2-hydroxy benzene sulfonic Acid/4-Ami nophenazone chromogenic system in direct enzymatic assay of uric acid in serum and urine. Clin Chem.1980;26(2):227-231. PMid:7353268

Hasler CM. A new look at an ancient concept. Chem. Industry Feb. 1998;2:84-89.

Abdel-Moaty M, Fouad S, El-Shebini S, et al. Serum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females. OA Maced J Med Sci. 2015;3(1):18-25.

Abdel-Moaty M, El-Shebini S, Ahmed N, et al. Serum Level of the Adipokine "Vaspin" in Relation to Metabolic Parameters: Short – Term Effect of Specific Dietary Therapy. Maced J Med Sci. 2014;7(2):185-190.

Després, J.P., I. Lemieux, J. Bergeron, P. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiovascular risk.Arterioscler Thromb Vasc Biol. 2008;28:1039-1049.


Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373.


Wortsman J, Matsuoka L, Chen T, et al. Decreased bioavailability of vitamin D in obesity. American Journal Clinical Nutrition. 2000;72(3):690–693. PMid:10966885

Mawer E, Backhouse J, Holman C, et al. The distribution and storage of vitamin D and its metabolites in human tissues. Clinical Science. 1972; 43 (3): 413–431.


Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases. 2007;17(7):517–524.


Ding C, Parameswaran V, Blizzard L, et al. Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. Journal of Internal Medicine. 2010;268(5):501–510.


Tzotzas T, Papadopoulou FG, Tziomalos K, et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance, J Clin Endocrinol Metab. 2010;95(5):4251.


Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism. 2005;90:4119–4123.


Portale AA & Miller WL. Human 25-hydroxylation D-1ahydroxylase: cloning, mutations, and gene expression. Pediatric Nephrology. 2000;14: 620–625.


Schiele F, Henny J, Hitz J, et al. Total bone and liver alkaline phosphatase in plasma: biological variations and reference limits. Clin Chem. 1983; 29:634-641.


Ishizaka N, Ishizaka Y, Toda E, et al. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005; 25:1038-1044.


Castrop H. Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine. Acta Physiol (Oxf). 2007;189:3-14.


Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ, Sambrook PN. Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone. 2013;52(1):400-406.




How to Cite

Moaty MI, Fouad S, El Shebini SM, Kazem YI, Tapozada ST. Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies. Open Access Maced J Med Sci [Internet]. 2015 Dec. 9 [cited 2021 Jun. 25];3(4):582-9. Available from:



A - Basic Science

Most read articles by the same author(s)